Evolus Inc (EVL.BE)
| Previous close | 8.85 |
| Open | 8.85 |
| Bid | 8.85 x 0 |
| Ask | 9.35 x 0 |
| Day's range | 8.85 - 9.05 |
| 52-week range | 6.15 - 10.50 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 06 Mar 2024 - 11 Mar 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Business WireEvolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEWPORT BEACH, Calif., December 08, 2023--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant in December of an aggregate of 28,328 restricted stock units (RSUs) of the company’s common stock to 7 newly hired non-executive employees of the company. The awards were approved by the compensation committee of the company’s board of directors under the Evolus’ 2023 Inducement Incentive Plan, with a gran
Insider MonkeyEvolus, Inc. (NASDAQ:EOLS) Q3 2023 Earnings Call Transcript
Evolus, Inc. (NASDAQ:EOLS) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Good afternoon, and welcome to the Evolus Third Quarter 2023 Earnings Conference Call. [Operator Instructions]. I would now like to turn the conference over to your host, Mr. Ned Mitchell from Investor Relations. Ned? Ned Mitchell: Thank you, operator, and welcome to everyone […]
Business WireEvolus Reports Record Third Quarter 2023 Financial Results and Phase II Data for Extra-Strength 40U Formulation of Jeuveau®
NEWPORT BEACH, Calif., November 07, 2023--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported financial results for the third quarter ended September 30, 2023.
